PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

Go back to PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
PACIFIC BIO CA (NASDAQ: PACB) Delayed: 1.32 -0.08 (5.71%)
Previous Close $1.40    52 Week High $14.00 
Open $1.38    52 Week Low $6.61 
Day High $1.41    P/E N/A 
Day Low $1.32    EPS $-1.26 
Volume 4,545,819